Catalio Capital Management

Portfolio Companies 2026 for Catalio Capital Management: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Catalio Capital Management accounts for 38 tracked companies with verified cap-table data, 38 of which disclose round sizes totalling $6.2B. The median disclosed raise is $128M, and the largest is InSightec at $800M, ahead of Neumora Therapeutics ($500M) and Flourish ($500M).

The names that recur most often on these portfolio cap tables are Catalio Capital Management (38 companies), Alexandria Venture Investments (5 companies), Novo Holdings (5 companies), ARCH Venture Partners (4 companies), F-Prime Capital (4 companies), Casdin Capital (4 companies). By latest disclosed round, the market skews Series B (13), Series A (11), Series D (4), Seed (4).

Best funded Catalio Capital Management companies

  1. InSightec — $800M (latest: Growth)
  2. Neumora Therapeutics — $500M (latest: Series A)
  3. Flourish — $500M (latest: Growth)
  4. FogPharma — $323M (latest: Series D)
  5. SetPoint Medical — $220M (latest: Series D)
  6. Paige — $220M (latest: Series C)
  7. Avalyn Pharma — $211M (latest: Series B)
  8. Entos — $206M (latest: Series A)
  9. Lila Sciences — $200M (latest: Seed)
  10. GlycoEra — $179M (latest: Series B)
  11. Affini-T Therapeutics — $175M (latest: Seed)
  12. ProSomnus Sleep Technologies — $168M (latest: IPO)
  13. Superluminal Medicines — $158M (latest: Series A)
  14. Surface Oncology — $150M (latest: Series A)
  15. Clasp Therapeutics — $150M (latest: Series A)

Catalio Capital Management, LP — related firms and companies (56)

Catalio Capital Management, LP profile · All research reports